FDA-CDC Antimicrobial Resistance Isolate Bank: a Publicly Available Resource To Support Research, Development, and Regulatory Requirements

J Clin Microbiol. 2018 Jan 24;56(2):e01415-17. doi: 10.1128/JCM.01415-17. Print 2018 Feb.

Abstract

The FDA-CDC Antimicrobial Resistance Isolate Bank was created in July 2015 as a publicly available resource to combat antimicrobial resistance. It is a curated repository of bacterial isolates with an assortment of clinically important resistance mechanisms that have been phenotypically and genotypically characterized. In the first 2 years of operation, the bank offered 14 panels comprising 496 unique isolates and had filled 486 orders from 394 institutions throughout the United States. New panels are being added.

Keywords: AR Bank; AR Isolate Bank; antibiotic resistance; antimicrobial resistance.

MeSH terms

  • Anti-Infective Agents / pharmacology
  • Bacteria / drug effects
  • Bacteria / genetics
  • Bacteria / isolation & purification*
  • Biological Specimen Banks* / organization & administration
  • Biological Specimen Banks* / standards
  • Centers for Disease Control and Prevention, U.S.
  • Communicable Diseases / diagnosis
  • Communicable Diseases / microbiology
  • Drug Resistance, Microbial*
  • Fungi / drug effects
  • Fungi / genetics
  • Fungi / isolation & purification*
  • Humans
  • United States
  • United States Food and Drug Administration

Substances

  • Anti-Infective Agents